Total Neoadjuvant Therapy vs Standard Therapy in Locally Advanced Rectal Cancer: A Systematic Review and Meta-analysis

医学 新辅助治疗 结直肠癌 放化疗 肿瘤科 随机对照试验 外科 内科学 辅助治疗 前瞻性队列研究 化疗 队列研究 全直肠系膜切除术 癌症 乳腺癌
作者
Anup Kasi,Saqib Abbasi,Shivani Handa,Raed Moh’d Taiseer Al-Rajabi,Anwaar Saeed,Joaquina Celebre Baranda,Weijing Sun
出处
期刊:JAMA network open [American Medical Association]
卷期号:3 (12): e2030097-e2030097 被引量:435
标识
DOI:10.1001/jamanetworkopen.2020.30097
摘要

Importance: Standard therapy for locally advanced rectal cancer includes concurrent chemoradiotherapy followed by surgery and adjuvant chemotherapy (CRT plus A). An alternative strategy known as total neoadjuvant therapy (TNT) involves administration of CRT plus neoadjuvant chemotherapy before surgery with the goal of delivering uninterrupted systemic therapy to eradicate micrometastases. A comparison of these 2 approaches has not been systematically reviewed previously. Objective: To determine the differences in rates of pathologic complete response (PCR), disease-free and overall survival, sphincter-preserving surgery, and ileostomy between patients receiving TNT vs standard CRT plus A. Data Sources: MEDLINE (via PubMed) and Embase (via OVID) were searched from inception through July 1, 2020, for the following terms: anal/anorectal neoplasms OR anal/anorectal cancer AND total neoadjuvant treatment OR total neoadjuvant therapy. Only studies in English were included. Study Selection: Randomized clinical trials or prospective/retrospective cohort studies comparing outcomes in patients with locally advanced rectal cancer who received TNT vs CRT plus A. Data Extraction and Synthesis: Data regarding the first author, publication year, location, sample size, and rates of PCR, sphincter-preserving surgery, ileostomy, and disease-free and overall survival were extracted using Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines and pooled using a random-effects model. Main Outcomes and Measures: Rates of PCR, sphincter-preserving surgery, ileostomy, and disease-free and overall survival. Results: After reviewing 2165 reports, 7 unique studies including a total of 2416 unique patients, of whom 1206 received TNT, were selected. The median age for the patients receiving TNT ranged from 57 to 69 years, with 58% to 73% being male. The pooled prevalence of PCR was 29.9% (range, 17.2%-38.5%) in the TNT group and 14.9% (range, 4.2%-21.3%) in the CRT plus A group. Total neoadjuvant therapy was associated with a higher chance of achieving a PCR (odds ratio [OR], 2.44; 95% CI, 1.99-2.98). No statistically significant difference in the proportion of sphincter-preserving surgery (OR, 1.06; 95% CI, 0.73-1.54) or ileostomy (OR, 1.05; 95% CI, 0.76-1.46) between recipients of TNT and CRT plus A was observed. Only 3 studies presented data on disease-free survival, and pooled analysis showed significantly higher odds of improved disease-free survival in patients who received TNT (OR, 2.07; 95% CI, 1.20-3.56; I2 = 49%). Data on overall survival were not consistently reported. Conclusions and Relevance: The findings of this systematic review and meta-analysis suggest that TNT is a promising strategy in locally advanced rectal cancer, with superior rates of PCR compared with standard therapy. However, the long-term effect on disease recurrence and overall survival needs to be explored in future studies.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
ooooo完成签到,获得积分10
1秒前
派派完成签到,获得积分20
1秒前
慕青的应助被叭叭驴采纳,获得10
1秒前
Azheng完成签到,获得积分10
1秒前
2秒前
ypp完成签到,获得积分10
2秒前
shiyi0709的应助被LJH采纳,获得10
2秒前
默默捕完成签到,获得积分10
3秒前
Hello的应助被xxxxxxh采纳,获得10
3秒前
星辰大海的应助被兔子采纳,获得10
3秒前
Yxianzi发布了新的文献求助30
4秒前
5秒前
黄油可颂发布了新的文献求助10
5秒前
Lei驳回了Maestro_S的应助
6秒前
派派发布了新的文献求助10
6秒前
6秒前
局敷衍完成签到 ,获得积分20
6秒前
顾矜的应助被Jiuuu采纳,获得10
6秒前
羅马完成签到,获得积分10
7秒前
8秒前
9秒前
9秒前
搜集达人的应助被wwwwyg采纳,获得10
9秒前
赵玉珊发布了新的文献求助10
9秒前
落寞的绯完成签到 ,获得积分10
10秒前
YU发布了新的文献求助10
10秒前
Oneone完成签到,获得积分10
10秒前
英姑的应助被常富育采纳,获得10
10秒前
努力搞科研完成签到,获得积分10
10秒前
aaaol发布了新的文献求助10
11秒前
12秒前
田様的应助被好心情采纳,获得30
12秒前
13秒前
13秒前
14秒前
luqiu完成签到,获得积分10
14秒前
hh完成签到 ,获得积分10
15秒前
15秒前
大方酶发布了新的文献求助20
15秒前
LIU完成签到,获得积分20
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8189302
求助须知:如何正确求助?哪些是违规求助? 9576666
关于积分的说明 21849295
捐赠科研通 7787245
什么是DOI,文献DOI怎么找? 3435521
关于科研通互助平台的介绍 2559748
邀请新用户注册赠送积分活动 2482509